Hubbry Logo
Heberden's nodeHeberden's nodeMain
Open search
Heberden's node
Community hub
Heberden's node
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Heberden's node
Heberden's node
Heberden's node
View on Wikipedia
from Wikipedia
Heberden's node
Heberden's nodes on the 2nd (index) finger of the right hand
SpecialtyRheumatology

Heberden's nodes are hard or bony swellings that can develop in the distal interphalangeal joints (DIP) (the joints closest to the end of the fingers and toes).[1] They are a sign of osteoarthritis and are caused by formation of osteophytes (calcific spurs) of the articular (joint) cartilage in response to repeated trauma at the joint.[2]

Heberden's nodes typically develop in middle age, beginning either with a chronic swelling of the affected joints or the sudden painful onset of redness, numbness, and loss of manual dexterity. This initial inflammation and pain eventually subsides, and the patient is left with a permanent bony outgrowth that often skews the fingertip sideways. Bouchard's nodes may also be present; these are similar bony growths in the proximal interphalangeal (PIP) joints (middle joints of the fingers), and are also associated with osteoarthritis.

Heberden's nodes are more common in women than in men, and there seems to be a genetic component involved in pre-disposition to the condition.

Eponym

[edit]

They are named after William Heberden (1710–1801).[3]

See also

[edit]
  • Bouchard's nodes – Also present in martial artists, in particular judoka and Brazilian jiu-jitsu practitioners.

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Heberden's node

View on Grokipedia
from Grokipedia
Heberden's nodes are small, bony growths or enlargements that form on the distal interphalangeal (DIP) joints of the fingers, closest to the fingertips, and are a hallmark clinical feature of hand (OA). These nodes result from the degeneration of articular cartilage in OA, leading to and the formation of osteophytes (bony spurs) as the body attempts to stabilize the affected joint. First described in the by British physician William Heberden in his work on diseases, they are often accompanied by similar swellings known as on the proximal interphalangeal (PIP) joints. Hand OA with Heberden's nodes primarily affects older adults, with a higher in women; studies indicate that approximately 50% of women and 25% of men over age 85 develop these nodes. Risk factors include advanced age, female sex, (such as family history of nodal OA), and repetitive hand use or microtrauma to the joints over time. In clinical cohorts, Heberden's nodes are present in about 86% of hand OA patients, most commonly on the third finger of the dominant hand, though they do not always correlate strongly with pain severity or functional impairment. Symptoms typically include joint pain, tenderness, stiffness (especially in the morning), swelling, and reduced in the affected fingers, which can make tasks like gripping objects or buttoning clothes challenging. The nodes themselves are usually painless once fully formed but may cause cosmetic concerns due to the knobby appearance of the fingers. Diagnosis is primarily clinical, based on revealing the characteristic swellings, often confirmed with X-rays showing space narrowing, osteophytes, and subchondral sclerosis. There is no cure for Heberden's nodes or the underlying OA, but management focuses on symptom relief and preserving function through conservative measures such as rest, splinting, heat or cold therapy, , and over-the-counter relievers like acetaminophen or nonsteroidal drugs (NSAIDs). In severe cases with significant or , surgical options like joint fusion may be considered. Prevention strategies emphasize maintaining a healthy weight, engaging in low-impact hand exercises, and following an diet to potentially slow OA progression.

Overview

Definition

Heberden's nodes are bony swellings or growths, specifically osteophytes, that develop on the dorsal aspect of the distal interphalangeal (DIP) joints of the fingers, which are the joints closest to the . These nodes are typically small, measuring about 2–5 mm or roughly pea-sized, and present as hard, palpable enlargements that are permanent once formed. They often affect multiple fingers and tend to occur symmetrically between hands. Heberden's nodes represent a primary clinical manifestation of hand , a degenerative characterized by breakdown and subsequent . They are distinct from , which form at the proximal interphalangeal (PIP) joints of the fingers.

Epidemiology

Heberden's nodes, bony enlargements at the distal interphalangeal joints indicative of hand , affect approximately 50% of women and 25% of men by age 85. The increases markedly with age, with radiographic evidence of hand reaching up to 80% in elderly populations overall. Nodes typically first appear in , around the 40s to 50s, particularly in women near , while they are rare in men under 50 years. Symptomatic hand , often featuring Heberden's nodes, shows a of 15.9% in women and 8.2% in men, rising to 26.2% in women and 13.4% in men over age 70. The condition is more common in postmenopausal women, with studies reporting Heberden's nodes in up to 85% of such patients with hand . Individuals with a family history of hand face a substantially higher , being up to 48 times more likely to develop Heberden's nodes compared to those without such history; for nodal hand OA is estimated at 40-60%. Nodes also occur more frequently in the dominant hand, with higher involvement in the distal interphalangeal joints of the preferred hand, such as 62.3% prevalence in the third finger's right distal joint among right-handed individuals. While Heberden's nodes generally align with overall rates, some studies suggest variations by ethnicity or race, with lower prevalence reported in non-Hispanic Black, Chinese, and South Asian populations compared to White or European groups. However, correlates with increased risk, as evidenced by higher values in affected cohorts, though the association is less pronounced for hand sites compared to joints.

Pathophysiology

Causes

Heberden's nodes primarily arise from (OA) of the hand, a degenerative condition characterized by the progressive breakdown of in the distal interphalangeal (DIP) joints. This erosion leads to bone-on-bone contact, instability, and subsequent formation at the margins. The underlying OA is multifactorial, with aging as a key contributor through natural on tissues over time, increasing susceptibility in individuals over 50 years. plays a significant role, with twin studies estimating of hand OA between 48% and 87%, indicating a strong inherited component influencing resilience and structure. Prior joint trauma, such as fractures or injuries, can initiate degenerative changes, while repetitive stress from occupations involving fine hand movements—like , assembly work, or use—accelerates degradation through chronic microtrauma. Hormonal factors, particularly the decline in levels following , contribute to breakdown in women by reducing protective effects on tissues and promoting pathways. This explains the higher in postmenopausal females. Unlike infectious or autoimmune conditions, Heberden's nodes have no microbial or systemic etiology and are primarily degenerative with features of low-grade , distinguishing OA from the more pronounced synovial seen in , which typically affects different patterns.

Mechanism

Heberden's nodes form as a consequence of (OA) primarily affecting the distal interphalangeal (DIP) joints of the fingers. In this process, progressive erosion of the articular exposes the underlying subchondral bone, which becomes subjected to increased mechanical stress and initiates a cascade of inflammatory responses. This exposure triggers the release of pro-inflammatory cytokines, such as interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-α), from chondrocytes and synovial cells, promoting further cartilage degradation through the upregulation of matrix metalloproteinases (MMPs) and inhibition of synthesis. The body's reparative response to this damage involves the proliferation of chondrocytes at the joint margins, leading to the formation of osteophytes, or bone spurs, which characterize Heberden's nodes. This process occurs through , where precursor cells differentiate into chondrocytes that hypertrophy and mineralize, eventually being replaced by bone tissue to stabilize the joint periphery. Osteophytes develop predominantly on the dorsal and lateral aspects of the DIP joints, contributing to the visible bony enlargements. The progression of node formation typically begins with initial synovial , marked by and infiltration of inflammatory cells, which exacerbates production. This is followed by gradual thinning and loss, resulting in space narrowing as detected on . Concurrent occurs in the subchondral region, with sclerosis and formation, while osteophytes continue to grow at the margins. Over time, the nodes stabilize, with active subsiding and the bony structures providing mechanical support, though persistent may limit function.

Clinical Presentation

Symptoms

Patients with Heberden's nodes often experience initial acute and tenderness at the distal interphalangeal during the formation of these bony outgrowths, which is typically exacerbated by use or activity. This inflammatory phase involves swelling and sensitivity, but the generally diminishes as the nodes mature and stabilize, transitioning to milder, activity-related discomfort that resolves with rest. In contrast to inflammatory arthritides, morning stiffness associated with Heberden's nodes is usually brief, lasting less than 30 minutes. Functional limitations are prominent, including reduced that affects the ability to hold objects firmly. Patients commonly report difficulty with fine motor tasks, such as buttoning clothing, writing, or manipulating small items, due to impaired mobility. Additionally, occasional —a grinding or crunching sensation—may occur during movement, accompanied by a of or fatigue in the affected digits from prolonged use.

Signs

Heberden's nodes manifest as firm, nontender bony enlargements primarily located on the dorsal and lateral aspects of the distal interphalangeal (DIP) joints of the fingers. These small, knobby protrusions typically first affect the index and middle fingers, with symmetrical involvement across both hands being common. In advanced cases, the nodes can contribute to visible finger deformities, such as mild flexion contractures at the affected DIP joints due to joint instability. They also result in limited at the affected DIP joints, restricting extension and flexion. Unlike inflammatory joint conditions, Heberden's nodes lack systemic signs such as fever or , as well as local inflammatory features like , warmth, or swelling.

Diagnosis

Physical Examination

The physical examination for Heberden's nodes focuses on a systematic assessment of the hands to identify characteristic features of distal interphalangeal (DIP) joint . Inspection begins by observing the dorsal aspect of the fingers for bony prominences or enlargements at the DIP joints, which appear as firm swellings often causing lateral deviation of the distal . These nodes are typically symmetric, affecting multiple fingers bilaterally, and spare the proximal interphalangeal (PIP) and metacarpophalangeal (MCP) joints in classic presentations. Alignment of the fingers should also be evaluated for any or zigzag deformities resulting from joint . Palpation follows to confirm the bony nature of the swellings, which feel hard and non-mobile due to underlying osteophytes, distinguishing them from softer subcutaneous lesions. Tenderness may be elicited over the nodes, particularly in early or active disease, but chronic nodes are often painless on direct pressure. Range-of-motion testing involves passively flexing and extending the DIP joints to assess for , reduced such as limited flexion and extension, and audible or palpable from degradation. No significant warmth or is expected, as these indicate inflammatory rather than degenerative processes. Functional evaluation quantifies impairment by measuring grip strength with a hand dynamometer, where reductions correlate with node severity and pain. Pinch strength tests, such as asking the patient to grasp small objects like a coin between the thumb and index finger, reveal deficits in fine motor dexterity often exacerbated by DIP involvement. In differential assessment, the absence of inflammatory signs like joint warmth, erythema, or boggy synovitis helps rule out conditions such as rheumatoid arthritis, where nodules are softer, more mobile, and typically occur over extensor surfaces rather than specifically at DIP joints. Heberden's nodes lack the acute tenderness or systemic features seen in gouty tophi or psoriatic arthritis, confirming their degenerative etiology through this non-invasive exam.

Imaging

Plain radiographs, particularly posteroanterior and lateral views of the hands, serve as the primary imaging modality for confirming Heberden's nodes and evaluating associated in the distal interphalangeal (DIP) joints. These X-rays typically reveal characteristic features of , including joint space narrowing due to loss, subchondral sclerosis from , marginal osteophytes representing bony outgrowths, and subchondral cyst formation indicative of intraosseous pressure changes. In cases of advanced disease, X-rays may demonstrate the "gull-wing" deformity, characterized by central joint erosions flanked by lateral osteophytes, particularly in erosive variants of hand . Advanced imaging techniques such as (MRI) or are not routinely employed for Heberden's nodes unless complications like soft tissue inflammation, , or involvement are suspected, as these modalities better assess periarticular structures. can detect osteophytes, synovial , and erosions with high sensitivity, while MRI provides detailed visualization of degeneration and in early or atypical presentations. However, plain radiographs remain sufficient for most diagnostic and monitoring purposes due to their accessibility and ability to quantify structural changes. Grading systems, such as the Kellgren-Lawrence scale adapted for hand joints, are commonly applied to radiographic findings to quantify severity and progression linked to Heberden's nodes. This scale assigns scores from 0 (no radiographic features) to 4 (severe space narrowing with multiple osteophytes and sclerosis), enabling standardized assessment of DIP joint involvement and correlation with clinical symptoms. Imaging is not invariably required for diagnosing Heberden's nodes when clinical features—such as palpable bony swellings at the DIP joints—are classic, as the condition is primarily a clinical supported by history and examination. Radiographs are reserved for confirmation in ambiguous cases, monitoring disease progression, or ruling out differentials like .

Management

Conservative Treatments

Conservative treatments for Heberden's nodes primarily aim to alleviate , reduce inflammation, and maintain joint function without invasive interventions. These approaches are recommended as first-line management for most patients, focusing on symptom and improving daily activities. Pharmacologic options include oral nonsteroidal drugs (NSAIDs) such as ibuprofen, which help reduce and swelling by inhibiting prostaglandin synthesis. Acetaminophen is often used as an alternative for when NSAIDs are contraindicated, particularly in patients with gastrointestinal concerns. For localized symptoms, topical NSAIDs or capsaicin creams provide targeted ; capsaicin depletes in nerve endings, diminishing signals after consistent application over several weeks. These medications are typically initiated at the lowest effective dose to minimize side effects like gastric irritation from oral agents or skin irritation from topicals. Non-drug therapies emphasize joint protection and mobility preservation. Nighttime splinting immobilizes the distal interphalangeal joints, reducing morning stiffness and pain while allowing rest; studies show this improves hand function in women with hand . Heat packs or warm paraffin baths increase blood flow and relax muscles, whereas cold packs constrict vessels to numb acute pain and decrease swelling—alternating these modalities can be tailored to patient preference. plays a key role, teaching adaptive techniques like joint protection principles (e.g., using larger grips to avoid pinching) and guided exercises to enhance dexterity without exacerbating . Lifestyle modifications support long-term symptom control by minimizing joint stress. Low-impact hand exercises, such as squeezing stress balls or performing gentle fist stretches, strengthen supporting muscles and maintain ; regular sessions of 10-15 minutes daily are recommended to prevent stiffness. Weight management reduces and overall joint load, even for hand involvement, through balanced diet and moderate activity. Ergonomic tools, including padded utensils or jar openers, distribute forces away from affected joints during routine tasks, promoting independence. Emerging conservative options include (LLLT), a non-invasive technique using red or near-infrared light to modulate cellular function and reduce inflammation. Clinical studies demonstrate that 5-7 sessions, administered twice weekly, significantly decrease pain (via ) and swelling (measured by joint perimeter) in Heberden's nodes, with benefits persisting up to 8 weeks post-treatment; improvements in mobility were also noted without adverse effects. Joint traction using a finger trap orthosis, applied daily for 15 minutes, has been shown to increase pinch strength in symptomatic distal interphalangeal joints, with benefits sustained up to 12 months post-treatment.

Surgical Options

Surgical interventions for Heberden's nodes are reserved for severe cases where persistent , significant , or functional impairment persists despite conservative management, and are relatively uncommon given the typically stable nature of the nodes. One primary procedure involves excision of the osteophytes forming the Heberden's nodes, often combined with joint debridement, particularly when associated with mucous cysts that risk nail or . This approach removes the bony prominences and any degenerative tissue to alleviate pressure and improve , with studies reporting low recurrence rates of approximately 2% when osteophytes are thoroughly addressed. Arthrodesis, or fusion of the distal interphalangeal (DIP) joint, is the most reliable surgical option for advanced symptomatic osteoarthritis causing Heberden's nodes, using techniques such as headless compression screws to achieve stability. The joint is typically positioned in full extension for the index and middle fingers or 10-20° flexion for the ring and little fingers to optimize function. Outcomes demonstrate high success, with union rates up to 100% and substantial pain reduction (e.g., visual analog scale scores dropping from 6.2 to 1.1 at 26-month follow-up), though nonunion occurs in about 10% of cases. In select cases, DIP joint arthroplasty with implants may be considered to preserve some motion, though it is less favored than fusion due to higher complication rates, including failure in up to 30% within 10 years. Postoperative recovery generally involves 4-6 weeks of immobilization in a splint or with , followed by hand therapy to restore strength and , with most patients achieving pain relief in 80-90% of cases but accepting reduced flexibility as a trade-off. Potential risks include infection, hardware irritation necessitating removal (in about 4% of fusions), stiffness, , or , and these procedures do not halt the underlying progression.

Prognosis and Complications

Outlook

Heberden's nodes represent permanent bony enlargements at the distal interphalangeal , resulting from the degenerative process of , and they do not regress once formed. While the underlying progresses over time, leading to potential worsening of , the associated symptoms—particularly and —often stabilize after node formation, with many patients experiencing reduced discomfort within a few years. With effective management, most individuals maintain satisfactory hand function, as evidenced by systematic reviews showing that only 23–59% report deterioration in hand function over 10 years, implying stability or preservation in the majority. Early therapeutic interventions, such as physical and , further improve long-term outcomes by enhancing and dexterity, allowing patients to perform daily activities with minimal impairment despite gradual declines in fine motor skills over decades. Hand involving Heberden's nodes does not impact and carries no risk of malignant transformation. Regular follow-up with healthcare providers is essential to monitor for progression of to other joints, enabling timely adjustments to treatment plans and preventing broader functional limitations.

Potential Complications

Heberden's nodes can lead to chronic functional limitations, including reduced in the distal interphalangeal (DIP) joints, grip weakness, and challenges with daily activities such as writing, buttoning clothing, or grasping small objects. These impairments arise from joint stiffness and deformity, potentially exacerbating over time. The condition may contribute to secondary osteoarthritis spreading to adjacent hand joints, such as the proximal interphalangeal (PIP) joints (forming ) or the carpometacarpal (CMC) joint of the thumb, though progression varies by individual factors like age and genetics. Rare complications include formation, particularly digital mucous cysts adjacent to the DIP joint, which can cause nail deformity or joint stiffness if untreated. Treatment-related issues include from prolonged splint use, which can weaken hand muscles if worn excessively beyond periods of acute pain or nighttime. Surgical interventions, such as joint fusion for severe cases, carry risks including rates of approximately 5-10%, along with potential or hardware prominence. Heberden's nodes may also have a psychological impact, with visible deformities causing frustration and reduced , though cosmetic concerns are generally minimal compared to functional effects.

History

Eponym

Heberden's nodes are named after William Heberden Sr. (1710–1801), an English physician renowned for his contributions to clinical medicine. He first described these bony swellings in his posthumously published 1802 book Commentaries on the History and Cure of Diseases, in a brief chapter entitled "Digitorum Nodi." In that section, Heberden characterized them as "little hard knobs, about the size of a small , which are frequently seen upon the fingers, a little below the top, close to the ," typically in older patients and linked to chronic arthritic changes. The eponymous term persists in contemporary and practice, despite recommendations to favor descriptive such as "distal interphalangeal osteophytes" to reflect their pathological nature as bony outgrowths in .

Historical Description

William Heberden provided the first detailed clinical description of the bony swellings now known as Heberden's nodes in his 1802 book Commentaries on the History and Cure of Diseases, where he termed them "nodi digitorum" and noted their prevalence in elderly women as hard, painless excrescences on the distal interphalangeal joints without significant inflammation. This account built upon scattered 18th-century observations of arthritic finger deformities in older individuals, though Heberden's work offered the earliest systematic characterization, emphasizing their chronic and non-inflammatory nature. In the , understanding advanced with links to ; Alfred B. Garrod, in the third edition of his 1876 treatise A Treatise on Gout and Rheumatic Gout, classified these nodes as part of degenerative joint disease, distinguishing them from inflammatory conditions like through clinical and chemical analyses that highlighted the absence of urate crystals. This differentiation marked a key step in , shifting focus from humoral theories to structural degeneration. Twentieth-century developments included radiographic confirmation in the early 1900s, with Joel E. Goldthwait using X-rays in 1904 to visualize changes underlying such nodes, revealing joint space narrowing and osteophytes that correlated with clinical findings. By the 1950s, pathological studies, such as Robert M. Stecher's 1955 analysis, confirmed the association through detailed clinical examinations and emerging histopathological evidence of degeneration and in affected joints. In the , genetic research, exemplified by twin studies from Timothy D. Spector and colleagues, established a strong for Heberden's nodes, with concordance rates up to 0.62 in monozygotic pairs indicating polygenic influences on nodal susceptibility. Post-2000 imaging refinements, including MRI protocols, have enhanced detection of early synovial and osseous changes, as shown in 2018 Osteoarthritis Initiative data linking node severity to progression via quantitative MRI assessments.

References

  1. https://my.clevelandclinic.org/health/symptoms/21829-heberdens-nodes
  2. https://www.ncbi.nlm.nih.gov/books/NBK482326/
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC6959971/
  4. https://pubmed.ncbi.nlm.nih.gov/33253392/
  5. https://www.utoledo.edu/med/depts/ortho/newsletter/pdfs/2020-12-December.pdf
  6. https://pmc.ncbi.nlm.nih.gov/articles/PMC9791555/
  7. https://newsnetwork.mayoclinic.org/n7-mcnn/7bcc9724adf7b803/uploads/2014/08/MCHL201408_SR2.pdf
  8. https://dermnetnz.org/topics/heberden-bouchard-nodes
  9. https://www.arthritis-uk.org/information-and-support/understanding-arthritis/conditions/osteoarthritis-of-the-hand-and-wrist/
  10. https://pmc.ncbi.nlm.nih.gov/articles/PMC1752580/
  11. https://www.sciencedirect.com/science/article/abs/pii/S0049017209000341
  12. https://www.verywellhealth.com/what-are-heberdens-nodes-2552023
  13. https://pubmed.ncbi.nlm.nih.gov/38360508/
  14. https://onlinelibrary.wiley.com/doi/10.1155/2016/2083683
  15. https://www.sciencedirect.com/science/article/abs/pii/S187713272300012X
  16. https://www.webmd.com/osteoarthritis/heberdens-nodes-symptoms-causes-treatments/
  17. https://www.mayoclinic.org/diseases-conditions/osteoarthritis/symptoms-causes/syc-20351925
  18. https://pubmed.ncbi.nlm.nih.gov/35843480/
  19. https://pmc.ncbi.nlm.nih.gov/articles/PMC4562436/
  20. https://nabilebraheim.wordpress.com/2021/03/30/osteoarthritis-of-the-fingers-heberdens-nodes-2/
  21. https://www.hopkinsarthritis.org/arthritis-info/osteoarthritis/oa-pathophysiology/
  22. https://pharmaceutical-journal.com/article/ld/osteoarthritis-pathophysiology-and-diagnosis
  23. https://www.mdpi.com/1422-0067/22/17/9208
  24. https://www.ncbi.nlm.nih.gov/books/NBK557808/
  25. https://www.aafp.org/pubs/afp/issues/2011/0515/p1203.html
  26. https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/acr.24385
  27. https://www.handtoshoulders.com/conditions-treated/fingers-osteoarthritis/
  28. https://www.arthritis.org/diseases/more-about/osteoarthritis-of-the-hands
  29. https://www.hopkinsarthritis.org/arthritis-info/osteoarthritis/signs-and-symptoms/
  30. https://med.stanford.edu/stanfordmedicine25/the25/hand.html
  31. https://www.physio-pedia.com/Pinch_Grip_Test
  32. https://radiopaedia.org/articles/osteoarthritis-of-the-hand?lang=us
  33. https://www.aafp.org/pubs/afp/issues/2001/0715/p279.html
  34. https://radiopaedia.org/articles/gull-wing-appearance-phalanges-1?lang=us
  35. https://www.sciencedirect.com/science/article/pii/S1063458414011145
  36. https://radiopaedia.org/articles/kellgren-and-lawrence-system-for-classification-of-osteoarthritis?lang=us
  37. https://oarsi.org/sites/oarsi/files/docs/2013/kellgrenlaw.pdf
  38. https://www.healthline.com/health/osteoarthritis/heberdens-nodes
  39. https://www.aafp.org/pubs/afp/issues/2012/0101/p49.html
  40. https://www.hopkinsarthritis.org/arthritis-info/osteoarthritis/oa-treatments/
  41. https://www.mayoclinic.org/diseases-conditions/osteoarthritis/in-depth/pain-medications/art-20045899
  42. https://pubmed.ncbi.nlm.nih.gov/32365314/
  43. https://www.the-rheumatologist.org/article/arhp-news-occupational-and-hand-therapy-in-treatment-of-osteoarthritis/
  44. https://www.mayoclinic.org/diseases-conditions/arthritis/in-depth/arthritis/art-20546847
  45. https://sanchetihospital.org/all-about-wear-and-tear-arthritis-of-the-hand/
  46. https://www.handtherapyacademy.com/treatments/7-tips-managing-hand-osteoarthritis/
  47. https://pubmed.ncbi.nlm.nih.gov/26833862/
  48. https://pmc.ncbi.nlm.nih.gov/articles/PMC11226916/
  49. https://www.orthobullets.com/hand/6055/dip-and-pip-joint-arthritis
  50. https://www.arthritis.org/health-wellness/treatment/joint-surgery/preplanning/hand-surgery-for-arthritis
  51. https://pmc.ncbi.nlm.nih.gov/articles/PMC11127517/
  52. https://pmc.ncbi.nlm.nih.gov/articles/PMC5954171/
  53. https://doi.org/10.1016/j.jhsa.2012.02.048
  54. https://www.bssh.ac.uk/patients/conditions/23/terminal_finger_joint_arthritis
  55. https://pmc.ncbi.nlm.nih.gov/articles/PMC12302428/
  56. https://pmc.ncbi.nlm.nih.gov/articles/PMC3959628/
  57. https://www.intechopen.com/chapters/48417
  58. https://www.ncbi.nlm.nih.gov/books/NBK559092/
  59. https://pmc.ncbi.nlm.nih.gov/articles/PMC4235825/
  60. https://www.physio-pedia.com/Wrist_and_Hand_Osteoarthritis
  61. https://academic.oup.com/rheumatology/article/43/5/664/1788291
  62. https://journals.lww.com/corr/fulltext/2004/10001/the_classic__commentaries_on_the_history_and_cure.2.aspx
  63. https://meridian.allenpress.com/aplm/article/124/12/1750/452470/The-Legacy-of-William-Heberden
  64. https://academic.oup.com/book/24708/chapter/188172275
  65. https://academic.oup.com/rheumatology/article-pdf/40/4/467/9533220/400467.pdf
  66. https://www.nber.org/system/files/chapters/c11110/c11110.pdf
Add your contribution
Related Hubs
User Avatar
No comments yet.